Literature DB >> 24963968

The impact of HPV infection, smoking history, age and operability of the patient on disease-specific survival in a geographically defined cohort of patients with oropharyngeal squamous cell carcinoma.

Borghild Ljøkjel1, Hilde Haave, Stein Lybak, Helene H Aarstad, Asa Karlsdottir, Olav K Vintermyr, Hans Jørgen Aarstad.   

Abstract

CONCLUSIONS: Patients with human papillomavirus (HPV)-positive tumours had better 5-year disease-specific survival (DSS) than HPV-negative patients. TNM score only predicted prognosis among HPV-negative patients. A previous history of smoking and age at diagnosis predicted DSS among HPV-positive patients whereas operability at diagnosis predicted DSS among both HPV-positive and HPV-negative patients.
OBJECTIVES: HPV is a risk factor for oropharyngeal squamous cell carcinoma (OPSCC). The extent to which smoking, age and operability could play a role in HPV-positive surgically treated head and neck SCCs has not been extensively addressed previously and this study aimed to evaluate these factors.
METHODS: We identified 232 patients with OPSCC, of which 186 from the tonsil or base of the tongue region were treated in the period 1992-2008 in Western Norway. The 5-year DSS was recorded. Details on smoking history and whether the lesion was operable or not, as well as clinical information, were obtained retrospectively from the hospital records.
RESULTS: TNM stage predicted survival only among HPV-negative patients. A previous smoking affected prognosis only among HPV-positive patients (relative risk (RR) = 2.5; confidence interval (CI) = 1.0-6.2; p = 0.05). Increasing age of the patient had a negative effect on survival in HPV-positive patients only, especially among the oldest quartile (RR = 4.4; CI = 2.0-9.0; p < 0.001). Whether the tumour was operable or not uniquely predicted DSS both among HPV-positive (RR = 0.34; CI = 0.13-0.93; p < 0.05) and HPV-negative (RR = 0.25; CI = 0.10-0.66; p < 0.01) patients with tonsil/base of the tongue SCC.

Entities:  

Keywords:  Human papillomavirus; age at diagnosis; disease stage; head and neck squamous cell carcinoma

Mesh:

Year:  2014        PMID: 24963968     DOI: 10.3109/00016489.2014.927590

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

1.  Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.

Authors:  Esther Mena; Mehdi Taghipour; Sara Sheikhbahaei; Abhinav K Jha; Arman Rahmim; Lilja Solnes; Rathan M Subramaniam
Journal:  Clin Nucl Med       Date:  2017-05       Impact factor: 7.794

2.  Impact of Smoking on the Survival of Patients With High-risk HPV-positive HNSCC: A Meta-analysis.

Authors:  Moonef Alotaibi; Valeria Valova; Toni HÄnsel; Carmen Stromberger; Grzegorz Kofla; Heidi Olze; Iris Piwonski; Andreas Albers; Sebastian Ochsenreither; Annekatrin Coordes
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.

Authors:  Stein Lybak; Borghild Ljøkjel; Hilde Haave; Àsa Karlsdottir; Olav K Vintermyr; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-04       Impact factor: 2.503

4.  Association Between Head and Neck Squamous Cell Carcinoma Survival, Smoking at Diagnosis, and Marital Status.

Authors:  Nosayaba Osazuwa-Peters; Eric Adjei Boakye; Betty Y Chen; Betelihem B Tobo; Mark A Varvares
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-01-01       Impact factor: 6.223

5.  20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes.

Authors:  Stephanie Y Chen; Aisling Last; Abhinav Ettyreddy; Dorina Kallogjeri; Benjamin Wahle; Smrithi Chidambaram; Angela Mazul; Wade Thorstad; Ryan S Jackson; Jose P Zevallos; Patrik Pipkorn
Journal:  Am J Otolaryngol       Date:  2021-01-13       Impact factor: 1.808

6.  In Vitro-Stimulated IL-6 Monocyte Secretion and In Vivo Peripheral Blood T Lymphocyte Activation Uniquely Predicted 15-Year Survival in Patients with Head and Neck Squamous Cell Carcinoma.

Authors:  Helene Hersvik Aarstad; Olav Karsten Vintermyr; Elling Ulvestad; Kenneth Kross; John Helge Heimdal; Hans Jorgen Aarstad
Journal:  PLoS One       Date:  2015-06-16       Impact factor: 3.240

Review 7.  Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.

Authors:  Linnea Haeggblom; Torbjörn Ramqvist; Massimo Tommasino; Tina Dalianis; Anders Näsman
Journal:  Papillomavirus Res       Date:  2017-05-19

8.  Targeted Next-Generation Sequencing of Cancer-Related Genes in a Norwegian Patient Cohort With Head and Neck Squamous Cell Carcinoma Reveals Novel Actionable Mutations and Correlations With Pathological Parameters.

Authors:  Harsh N Dongre; Hilde Haave; Siren Fromreide; Fredrik A Erland; Svein Erik Emblem Moe; Sophia Manueldas Dhayalan; Rasmus Kopperud Riis; Dipak Sapkota; Daniela Elena Costea; Hans Jorgen Aarstad; Olav K Vintermyr
Journal:  Front Oncol       Date:  2021-09-24       Impact factor: 6.244

9.  Impact on survival of tobacco smoking for cases with oropharyngeal squamous cell carcinoma and known human papillomavirus and p16-status: a multicenter retrospective study.

Authors:  Christian Grønhøj; Jakob Schmidt Jensen; Steffen Wagner; Christian Dehlendorff; Jeppe Friborg; Elo Andersen; Claus Wittekindt; Nora Würdemann; Shachi Jenny Sharma; Stefan Gattenlöhner; Jens Peter Klussmann; Christian von Buchwald
Journal:  Oncotarget       Date:  2019-07-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.